ORIGINAL ARTICLES

Serological epidemic characteristics of transient population at national schistosomiasis surveillance sites of China, 2020-2022

  • GUO Suying ,
  • LI Yinlong ,
  • LI Shizhen ,
  • DANG Hui ,
  • CAO Chunli ,
  • XU Jing ,
  • LI Shizhu
Expand
  • 1 National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; Chinese Center for Tropical Diseases Research; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases;Key Laboratory on Parasite and Vector Biology, Ministry of Health; WHO Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China
    2 School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2024-09-02

  Revised date: 2024-12-05

  Online published: 2025-01-14

Supported by

Shanghai Municipal Health Commission Health Industry Clinical Research Special Project(20214Y0212);National Science Foundation of China(82073619)

Abstract

Objective To analyze the seroepidemiological characteristics in transient population and the moving direction of the individuals with positive serum anti-schistosome antibody at national schistosomiasis surveillance sites of China during 2020-2022, and to provide a scientific basis for formulating surveillance program for schistosomiasis in the transient population. Methods Data of the national population-based schistosomiasis surveillance and individual cases recorded from transient population during 2020-2022 were collected from the Information System for Infectious Diseases Prevention and Control and the Information System for Parasitic Disease Prevention and Control. The data include demographic characteristics of sex, age, occupation and the counties of residence registered, and the people migrating information regarding the locations of moving in or moving out from, as well as the results of serological and pathogenic examinations for schistosomiasis. Descriptive epidemiological methods were employed to analyze the spatial, temporal, and demographic distribution of the serum anti-schistosome level among the transient population. Chi-square analysis was used to compare the differences in the positive rates of serum antibodies among the groups of sex, age, and occupation. Partitions of χ2 method was used for multiple comparisons of the positive rates. Sankey diagram was used to describe the moving direction of the individuals with positives serum antibodies. Results A total of 302 460 person-time among the transient population was surveyed from 455 surveillance counties in 13 provinces (or autonomous regions or municipalities) in China from 2020 to 2022, and 1 199 was found positive with serum antibodies, and one was positive with fecal examination. During 2020-2022, the positive rates of serum antibodies among the transient population were 0.47% (450/96 596), 0.44% (442/101 558), and 0.29% (307/104 306), respectively. The rates in 2020 and 2021 were both higher than the rate in 2022 (χ2 = 39.310, 28.178; both P < 0.01). During 2020-2022, the highest positive rates of serum antibodies were detected in Jiangxi, showing 1.24% (91/7 316), 1.33% (112/8 412), and 0.65% (56/8 648), respectively. The positive rates of serum antibodies were 0.48% (277/57 550), 0.44% (260/59 458), and 0.31% (191/62 237) in males and 0.44% (173/39 046), 0.43% (182/42 100), and 0.28% (116/42 069) in females, respectively. No statistically significant differences were observed between sex groups in each year (χ2 = 0.734, 0.014, 0.830; all P > 0.05). The positive rates of serum antibodies were 0.82% (225/27 561), 0.78% (226/28 928) and 0.53% (158/29 661) in farmers, 0.86% (20/2 333), 0.75% (16/2 141) and 0.91% (23/2 523) in boatmen/fishermen, and 0.31% (205/66 702), 0.28% (200/70 489) and 0.17% (126/72 122) in other occupation group, respectively. The positive rates of serum antibodies were higher in the farmers and boatmen/fishermen groups compared to the other occupation group (χ2 = 111.287, 118.991, 96.799; 20.985, 15.060, 66.450; all P < 0.01). The positive rates of serum antibodies in group of 6-15 years were the highest (1.00%, 16/1 597) in 2020, the second highest (0.70%, 10/1 436) in 2021, and the lowest (0.05%, 1/1 836) in 2022, respectively. The differences among different age groups were statistically significant for each year (χ2 = 41.282, 56.515, 54.425; all P < 0.01). Among the seropositive individuals who provided complete information on their migration regions, higher proportions of emigration location were seen from Sichuan (21.86%, 256/1 171), Jiangxi (21.18%, 248/1 171), and Hubei (18.02%,211/1 171), and the highest two destinations were Jiangxi (18.87%, 221/1 171) and Sichuan (18.87%, 221/1 171). Among the seropositive individuals who provided complete migration information, higher proportions of emigration location were seen from Sichuan (21.86%, 256/1 171), Jiangxi (21.18%, 248/1 171), and Hubei (18.02%, 211/1 171). The higher proportions of immigration location were seen in Jiangxi (18.87%, 221/1 171) and Sichuan (18.87%, 221/1 171); the proportion of immigration location within or between non-eliminated provinces was 73.87% (865/1 171), and the proportion of migrants moving between non-eliminated and eliminated provinces was 19.98% (234/1 171). Forty-six individuals with positive serum antibodies migrated from non-endemic areas to endemic areas. Conclusion According to the survey of the national surveillance sites, the prevalence of schistosomiasis in transient population in China remained at a very low level from 2020 to 2022. It is imperative to strengthen the surveillance for the transient population in Jiangxi, younger age group and the migrants moving in or out from non-elimination areas, as well as the proper management of people with past infections.

Cite this article

GUO Suying , LI Yinlong , LI Shizhen , DANG Hui , CAO Chunli , XU Jing , LI Shizhu . Serological epidemic characteristics of transient population at national schistosomiasis surveillance sites of China, 2020-2022[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024 , 42(6) : 694 -700 . DOI: 10.12140/j.issn.1000-7423.2024.06.002

References

[1] Zhou XN, Wang LY, Chen MG, et al. The public health significance and control of schistosomiasis in China: then and now[J]. Acta Trop, 2005, 96(2-3): 97-105.
[2] Xu J, Cao CL, Lv S, et al. Schistosomiasis control in China from 2012 to 2021: progress and challenges[J]. Chin J Schisto Control, 2022, 34(6): 559-565. (in Chinese)
  (许静, 曹淳力, 吕山, 等. 血吸虫病防治这10年: 进展与挑战[J]. 中国血吸虫病防治杂志, 2022, 34(6): 559-565.)
[3] Zhang LJ, Xu ZM, Dang H, et al. Endemic status of schistosomiasis in People’s Republic of China in 2019[J]. Chin J Schisto Control, 2020, 32(6): 551-558. (in Chinese)
  (张利娟, 徐志敏, 党辉, 等. 2019年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2020, 32(6): 551-558.)
[4] Liang Z, Li Z, Ma Z. Changing patterns of the floating population in China during 2000-2010[J]. Popul Dev Rev, 2014, 40(4): 695-716.
[5] Wang Q, Feng T, Qin ZQ, et al. Risk assessment of schistosomiasis transmission by catalytic models based on antibody positive rates[J]. Chin J Parasitol Parasit Dis, 2016, 34(5): 418-423. (in Chinese)
  (王强, 冯婷, 秦志强, 等. 基于抗体阳性率的催化模型评估血吸虫病的传播风险[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(5): 418-423.)
[6] Wang XH, Zhou XN, Wu XH, et al. Study on the spatio-temporal distribution of seroprevalence of Schistosoma japonicum[J]. Chin J Parasitol Parasit Dis, 2008, 26(4): 290-298. (in Chinese)
  (王显红, 周晓农, 吴晓华, 等. 日本血吸虫血清学阳性率时空分布格局的初步研究[J]. 中国寄生虫学与寄生虫病杂志, 2008, 26(4): 290-298.)
[7] Dang H, Li YL, Lv S, et al. Interpretation for National Surveillance Plan of Schistosomiasis (version 2020)[J]. J Trop Dis Parasitol, 2020, 18(3): 133-137. (in Chinese)
  (党辉, 李银龙, 吕山, 等. 《全国血吸虫病监测方案(2020年版)》释义[J]. 热带病与寄生虫学, 2020, 18(3): 133-137.)
[8] Guo S, Dang H, Li Y, et al. Sentinel surveillance of schisotosomiasis-China, 2021[J]. China CDC Weekly, 2023, 5(12): 278-282.
[9] Zhou H. Comparison of statistical caliber for migrant and floating population in China[J]. Popul Econom, 2024, (4): 32-44. (in Chinese)
  (周皓. 中国迁移流动人口统计口径比较[J]. 人口与经济, 2024, (4): 32-44.)
[10] Li J, Wen YS, Li ZJ. Effect of tourism development on schistosomiasis control in China[J]. Chin J Parasitol Parasit Dis, 2023, 41(3): 355-360. (in Chinese)
  (李婕, 文雨松, 李召军. 我国旅游开发对血吸虫病防治的影响[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(3): 355-360.)
[11] General Office of the Ministry of Health. Notice of the issuance of the National Surveillance Plan of Schistosomiasis (trial) and the National Surveillance Plan of Malaria (trial) by the General Office of the Ministry of Health[J]. Gazette of the Ministry of Health of P.R.C., 2005, 6: 52-58. (in Chinese)
  (卫生部办公厅. 卫生部办公厅关于印发《全国血吸虫病监测方案》(试行)和《全国疟疾监测方案》(试行)的通知[J]. 卫生部公报, 2005, 6: 52-58.)
[12] Wu JL, Li B, Liu S, et al. Assessment of transmission risk of human schistosomiasis japonica based on human population antibody level in Hubei Province[J]. Chin J Parasitol Parasit Dis, 2021, 39(5): 578-584. (in Chinese)
  (吴家利, 李博, 刘斯, 等. 基于人群抗体水平的湖北省血吸虫病传播风险分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(5): 578-584.)
[13] Zhou Y, Tang L, Tong YX, et al. Spatial distribution characteristics of the prevalence of advanced schistosomiasis and seroprevalence of anti-Schistosoma antibody in Hunan Province in 2020[J]. Chin J Schisto Control, 2023, 35(5): 444-450. (in Chinese)
  (周雨, 汤凌, 童懿昕, 等. 2020年湖南省居民晚期血吸虫患病率与血清抗血吸虫抗体阳性率空间分布特征[J]. 中国血吸虫病防治杂志, 2023, 35(5): 444-450.)
[14] Guan Z, Lv S, Li SZ, et al. Analysis on the situation of schistosome infections in floating population in national schistosomiasis surveillance sites of China[J]. Chin J Schisto Control, 2018, 30(2): 124-130. (in Chinese)
  (关周, 吕山, 李石柱, 等. 全国血吸虫病监测点流动人口血吸虫感染情况分析[J]. 中国血吸虫病防治杂志, 2018, 30(2): 124-130.)
[15] Dang H, Li YL, Guo JY, et al. National surveillance of schistosomiais morbidity in China, 2015-2019[J]. Chin J Schisto Control, 2021, 33(2): 120-126. (in Chinese)
  (党辉, 李银龙, 郭婧怡, 等. 2015—2019年全国血吸虫病监测点病情监测结果分析[J]. 中国血吸虫病防治杂志, 2021, 33(2): 120-126.)
[16] Zhou XN, Zhu ZL, Tu H, et al. Interpretation of Actions for Accelerating the Progress towards Elimination of Schistosomiasis in China (2023-2030)[J]. Chin J Schisto Control, 2024, 36(1): 7-12. (in Chinese)
  (周晓农, 朱泽林, 涂宏, 等. 《加快实现消除血吸虫病目标行动方案(2023—2030年)》解读[J]. 中国血吸虫病防治杂志, 2024, 36(1): 7-12.)
[17] Yang F, Xu J, Lv S, et al. Analysis on epidemiological characteristics of current advanced schistosomiasis cases in China based on the Epidemiological Dynamic Data Colleciton Platform (EDDC)[J]. Chin J Schisto Control, 2021, 33(3): 234-239. (in Chinese)
  (杨帆, 许静, 吕山, 等. 基于EDDC平台的全国现存晚期血吸虫病患者流行病学特征分析[J]. 中国血吸虫病防治杂志, 2021, 33(3): 234-239.)
[18] Guo SY, Zhu HQ, Cao CL, et al. Risk assessment of schistosomiasis transmission along the middle and lower reaches of Yantze River after flooding in 2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(6): 753-759. (in Chinese)
  (郭苏影, 祝红庆, 曹淳力, 等. 2020年长江中下游地区洪涝灾害后血吸虫病传播风险评估[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(6): 753-759.)
[19] Cao CL. Review and evaluation of health education and health promotion of schistosomiasis control in China[J]. China Trop Med, 2020, 20(7): 599-607. (in Chinese)
  (曹淳力. 中国防治血吸虫病健康教育和健康促进的回顾与评估[J]. 中国热带医学, 2020, 20(7): 599-607.)
Outlines

/

〈 〉